Amyloid-beta Aggregate Determination Assay Service
By detecting the various stages of amyloid-beta (Aβ) aggregates, researchers can more accurately assess the efficacy of potential therapeutic interventions and identify significant biomarkers for the development of novel drugs. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Introduction
Aβ aggregates are a key pathological feature of neurodegenerative diseases such as Alzheimer's disease (AD). Studies have shown that Aβ peptides accumulate in the brain and form fibrillar aggregates that are toxic to neurons, leading to cognitive impairment and dementia. Accurate detection and analysis of Aβ aggregates is therefore critical to understanding their role in the disease.
Available Assays at Creative Biolabs
- Aggregated Aβ Assay
Aβ monomers can self-assemble into low-molecular-weight oligomers, further form high-molecular-weight fibrillar structures, and finally deposit as amyloid plaques. Aβ aggregation is a dynamic process involving two stages: nucleation and polymerization, in which stable seeds (such as fibril fragments) serve as polymerization templates to accelerate aggregation. Our Aβ aggregation service is suitable for a variety of samples, including brain homogenate, cerebrospinal fluid, in vitro aggregated Aβ, and various cell culture samples.
For downstream detection, we can provide thioflavin T (ThT) or enzyme-linked immunosorbent assay (ELISA) based assays to detect the kinetics of Aβ aggregation.
ThT Assay
ThT is a commonly used dye that can specifically bind to amyloid fibrils and assess the formation of Aβ aggregates by monitoring changes in fluorescence intensity.
Fig.1 ThT fluorescence intensity correlated linearly with amyloid fibril concentration.2, 5
ELISA Assay
ELISA is commonly used to detect Aβ40 and Aβ42 aggregates by using specific antibodies to detect and quantify Aβ aggregates.
Fig.2 Total and fibril levels of Aβ1-40 and Aβ1-42 were analyzed by ELISA.3, 5
- Mass Spectrometry Analysis
Mass spectrometry can be used to identify and quantify the peptide composition of Aβ aggregates, helping to understand their structural and functional properties. Liquid chromatography-mass spectrometry can be used to analyze the composition of Aβ oligomers and fibers.
Fig.3 Human AD brain soluble Aβ aggregates mass spectrometry.4, 5
The specific method selected depends on the purpose of the experiment, the type of sample, and the resolution required. A combination of methods can provide a more comprehensive understanding of the mechanism of Aβ aggregation and its role in neurodegenerative diseases. Our services have helped many scientific research institutions and pharmaceutical companies achieve significant research results. Please contact us and we will match you with the most suitable Ph.D. scientist to communicate with you about your research and accelerate your plan.
References
- Polanco, David, et al. "Characterisation of Amyloid Aggregation and Inhibition by Diffusion-Based Single-Molecule Fluorescence Techniques." Biophysica 2.4 (2022): 506-524.
- Xue, Christine, et al. "Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation." Royal Society open science 4.1 (2017): 160696.
- Sehlin, Dag, et al. "Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation." PloS one 7.2 (2012): e32014.
- Esparza, Thomas J., et al. "Soluble amyloid-beta aggregates from human Alzheimer's disease brains." Scientific reports 6.1 (2016): 38187.
- Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P515) (Cat#: NRP-0422-P515)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)